HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cicatricial pemphigoid of the oropharynx after allogeneic stem cell transplantation for relapsed follicular lymphoma.

Abstract
A 44-year-old woman with refractory follicular lymphoma underwent allogeneic stem cell transplantation (SCT) and achieved complete remission. Grade III acute graft-versus-host disease (GVHD) developed on day 23, but no chronic GVHD occurred. The patient developed severe erosion with bullous lesions in the oral cavity 18 months after SCT. At that time, the lymphoma remained in complete remission, and she had no clinical or laboratory findings suggesting chronic GVHD. A biopsy of the oral mucosa showed moderate lymphoplasmacytic infiltration and subepidermal bullae, and direct immunofluorescence staining demonstrated linear deposition of C3 at the dermo-epidermal junction. An immunoblotting assay using human epidermal extracts confirmed the presence in her serum of an antibody against the 230-kd bullous pemphigoid antigen 1 (BPAG1). A diagnosis of cicatricial pemphigoid (CP) was made, and complete resolution of the CP was achieved with prednisolone therapy. The occurrence of autoimmune blistering diseases is rare after allogeneic SCT.
AuthorsYoshinobu Aisa, Takehiko Mori, Tomonori Nakazato, Rie Yamazaki, Jun Yamagami, Masayuki Amagai, Yasuo Ikeda, Shinichiro Okamoto
JournalInternational journal of hematology (Int J Hematol) Vol. 82 Issue 3 Pg. 266-9 (Oct 2005) ISSN: 0925-5710 [Print] Japan
PMID16207603 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Prednisolone
Topics
  • Adult
  • Anti-Inflammatory Agents (therapeutic use)
  • Female
  • Graft vs Host Disease (drug therapy, etiology, pathology)
  • Humans
  • Lymphoma, Follicular (complications, pathology, therapy)
  • Mouth (pathology)
  • Oropharynx (pathology)
  • Pemphigoid, Benign Mucous Membrane (drug therapy, etiology, pathology)
  • Prednisolone (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: